Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.
BACKGROUND: Multiple myeloma (MM) expands almost exclusively in the bone marrow and generates devastating bone lesions, in which bone formation is impaired and osteoclastic bone resorption is enhanced. TGF-beta, a potent inhibitor of terminal osteoblast (OB) differentiation, is abundantly deposited...
Príomhchruthaitheoirí: | , , , , , , , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Public Library of Science (PLoS)
2010-01-01
|
Sraith: | PLoS ONE |
Rochtain ar líne: | http://europepmc.org/articles/PMC2845613?pdf=render |